Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.
IRONMAN Investigators; Litton E, Baker S, Erber WN, Farmer S, Ferrier J, French C, Gummer J, Hawkins D, Higgins A, Hofmann A, De Keulenaer B, McMorrow J, Olynyk JK, Richards T, Towler S, Trengove R, Webb S; Australian and New Zealand Intensive Care Society Clinical Trials Group. IRONMAN Investigators, et al. Among authors: olynyk jk. Intensive Care Med. 2016 Nov;42(11):1715-1722. doi: 10.1007/s00134-016-4465-6. Epub 2016 Sep 30. Intensive Care Med. 2016. PMID: 27686346 Clinical Trial.
Diagnosis and management of iron deficiency anaemia: a clinical update.
Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL. Pasricha SR, et al. Among authors: olynyk jk. Med J Aust. 2010 Nov 1;193(9):525-32. doi: 10.5694/j.1326-5377.2010.tb04038.x. Med J Aust. 2010. PMID: 21034387 Review.
The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.
Litton E, Baker S, Erber W, French C, Ferrier J, Hawkins D, Higgins AM, Hofmann A, Keulenaer BL, Farmer S, McMorrow J, Olynyk J, Richards T, Towler S, Webb S; Australian and New Zealand Intensive Care Society Clinical Trials Group. Litton E, et al. Crit Care Resusc. 2014 Dec;16(4):285-90. Crit Care Resusc. 2014. PMID: 25437223 Clinical Trial.
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P; HERO Study Collaborative Group. Gummer J, et al. Among authors: olynyk jk. Nephrology (Carlton). 2017 Jul;22(7):548-554. doi: 10.1111/nep.12815. Nephrology (Carlton). 2017. PMID: 27171136 Clinical Trial.
Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study.
Litton E, Baker S, Erber W, Farmer S, Ferrier J, French C, Gummer J, Hawkins D, Higgins A, Hofmann A, De Keulenaer B, McMorrow J, Olynyk JK, Richards T, Towler S, Trengove R, Webb S; IRONMAN Study investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Litton E, et al. Among authors: olynyk jk. J Intensive Care. 2018 Sep 10;6:60. doi: 10.1186/s40560-018-0328-2. eCollection 2018. J Intensive Care. 2018. PMID: 30214812 Free PMC article.
255 results